Ruling out risks in medical research
| Autor: | Niklas Vareman, Nils-Eric Sahlin, Sten Anttila, Johannes Persson, Måns Rosén, Sigurd Vitols |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2019 |
| Předmět: |
Medical Ethics
010504 meteorology & atmospheric sciences Strategy and Management 0211 other engineering and technologies Accounting 02 engineering and technology Health benefits 01 natural sciences Value judgment Safety Risk Reliability and Quality Ruling out risks Consolidated Standards of Reporting Trials (CONSORT) 0105 earth and related environmental sciences transparency 021110 strategic defence & security studies Risk margin business.industry General Engineering General Social Sciences risk margin Medical research Transparency (behavior) value judgment Philosophy Balance (accounting) Business Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) Medical ethics |
| Zdroj: | Journal of Risk Research; 22(6), pp 796-802 (2019) |
| ISSN: | 1366-9877 |
| Popis: | In medical research, it is not unusual that risks are ruled out without any specification the exact risk that was ruled out. This makes it difficult to balance expected health benefits and risk of harm when choosing between alternative treatment options. International guidelines for reporting medical research results are sufficiently specific when it comes to establishing health benefits. However, there is a lack of standards for reporting on ruling out risks. We argue that transparency is needed, as in the case of non-inferiority trials. The Consolidated Standards of Reporting Trials and the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statements should be revised accordingly. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|